Form 4: Elevance Health CAO & Controller Ronald W. Penczek Reports Sale of Common Stock
SEC Form 4 Filing
Ronald W. Penczek, CAO & Controller of Elevance Health, Inc., reported selling 916 shares of common stock on March 6, 2024.
Summary
- On March 6, 2024, Ronald W. Penczek, the CAO & Controller of Elevance Health, Inc. (ELV), sold 916 shares of the company's common stock.
- The sale was executed at a weighted average price of $504.58 per share.
- Following the transaction, Penczek directly owns 1,764 shares of Elevance Health common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of an insider stock sale. The sentiment is neutral as it doesn't inherently indicate positive or negative news about the company's performance.
Industry Context
This is a standard Form 4 filing, indicating a change in beneficial ownership by a company insider. These filings are routinely monitored by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The sale of shares by a company insider could be perceived negatively by some shareholders, although it is a common occurrence and doesn't necessarily reflect a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction: Ronald W. Penczek sold 916 shares of Elevance Health common stock. |
| 03/08/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.